695,000 Shares in GE HealthCare Technologies Inc. $GEHC Bought by Employees Retirement System of Texas

Employees Retirement System of Texas purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 695,000 shares of the company’s stock, valued at approximately $52,195,000. Employees Retirement System of Texas owned approximately 0.15% of GE HealthCare Technologies at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in GEHC. Sei Investments Co. boosted its position in shares of GE HealthCare Technologies by 17.2% during the 3rd quarter. Sei Investments Co. now owns 274,975 shares of the company’s stock worth $20,653,000 after purchasing an additional 40,334 shares in the last quarter. Franklin Resources Inc. boosted its holdings in GE HealthCare Technologies by 3.7% in the third quarter. Franklin Resources Inc. now owns 488,448 shares of the company’s stock worth $36,682,000 after acquiring an additional 17,544 shares in the last quarter. Van ECK Associates Corp boosted its holdings in GE HealthCare Technologies by 3.2% in the third quarter. Van ECK Associates Corp now owns 4,497,827 shares of the company’s stock worth $337,787,000 after acquiring an additional 139,404 shares in the last quarter. Capital Research Global Investors boosted its holdings in GE HealthCare Technologies by 25.0% in the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after acquiring an additional 4,998,154 shares in the last quarter. Finally, Legal & General Group Plc grew its stake in GE HealthCare Technologies by 7.1% in the third quarter. Legal & General Group Plc now owns 2,900,935 shares of the company’s stock valued at $217,860,000 after acquiring an additional 192,818 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 3.2%

Shares of GE HealthCare Technologies stock opened at $70.33 on Friday. The company has a market capitalization of $32.05 billion, a P/E ratio of 15.42, a price-to-earnings-growth ratio of 1.60 and a beta of 1.03. The stock has a fifty day simple moving average of $81.02 and a 200 day simple moving average of $78.51. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $89.77. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. The business had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.07%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their target price for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Wall Street Zen upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Evercore upped their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Bank of America raised their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research note on Monday, January 5th. Finally, Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Hold” and an average price target of $92.17.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.